Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Medtronic
Baxter

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022114

See Plans and Pricing

« Back to Dashboard

NDA 022114 describes ZINGO, which is a drug marketed by Powder Pharms and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the ZINGO profile page.

The generic ingredient in ZINGO is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 022114
Tradename:ZINGO
Applicant:Powder Pharms
Ingredient:lidocaine hydrochloride
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 022114
Physiological EffectLocal Anesthesia
Suppliers and Packaging for NDA: 022114
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114 NDA AUTHORIZED GENERIC SA3, LLC 69420-1230 69420-1230-1 1 POWDER in 1 POUCH (69420-1230-1)
ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114 NDA AUTHORIZED GENERIC SA3, LLC 69420-1230 69420-1230-2 12 POUCH in 1 CARTON (69420-1230-2) > 1 POWDER in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYSTEM;INTRADERMALStrength0.5MG
Approval Date:Aug 16, 2007TE:RLD:No
Patent:  Start TrialPatent Expiration:Oct 22, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO INTRADERMAL INJECTION SYSTEM IS A DRUG DELIVERY SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION
Patent:  Start TrialPatent Expiration:Apr 27, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION
Patent:  Start TrialPatent Expiration:Sep 28, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION

Expired US Patents for NDA 022114

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007   Start Trial   Start Trial
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007   Start Trial   Start Trial
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007   Start Trial   Start Trial
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
AstraZeneca
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.